Waters Corporation Schedules Second Quarter 2026 Earnings Conference Call
Rhea-AI Summary
Waters (NYSE: WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m. Eastern Time. A live webcast and replay will be available on the company’s Investor Relations website until at least September 1, 2026.
Waters is a global life sciences and diagnostics company focused on analytical technologies, informatics, and services for regulated, high-volume testing environments, supporting medicine development, food and water safety, and disease detection.
Positive
- None.
Negative
- None.
News Market Reaction – WAT
On the day this news was published, WAT gained 0.31%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Jun 24 | AI partnership | Positive | +3.4% | Strategic AI-powered immune mapping collaboration with IMU Biosciences. |
| Jun 09 | Product launch | Positive | +2.9% | Launch of Coin Cell DSC platform targeting battery safety testing. |
| Jun 08 | Product launch | Positive | -0.0% | New reversed-phase columns for faster GLP-1 and LNP analysis. |
| Jun 03 | Regulatory clearance | Positive | +2.1% | FDA 510(k) clearance for BD BACTEC FXI Culture System. |
| Jun 01 | Product launch | Positive | -1.4% | Launch of Cyclic IMS P20 high-resolution omics mass spectrometer. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent product and partnership headlines have produced mixed but often positive single-day moves, indicating investors respond selectively to operational updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
About Waters Corporation
Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.
Caspar Tudor, Head of Investor Relations
investor_relations@waters.com
View original content:https://www.prnewswire.com/news-releases/waters-corporation-schedules-second-quarter-2026-earnings-conference-call-302816469.html
SOURCE Waters Corporation